Dendreon | Evaluate

January 17, 2017

M&A in 2016: Pause for breath in a shifting market

January 11, 2017

JP Morgan day two roundup – all talk, very little action

January 10, 2017

JP Morgan – Valeant finds a way to make Dendreon profitable

August 10, 2016

A new Valeant starts to take shape, and it's still not pretty

August 04, 2016

Inovio gets the final farewell from Roche

March 16, 2016

One way to save Valeant – stop being Valeant

March 07, 2016

Adopt Summit – Manufacturing is still the biggest hurdle for CAR-T

December 21, 2015

Medigene keeps eyes on immunotherapy prize

December 08, 2015

ASH – CAR-T struggles to travel beyond leukaemia

December 04, 2015

Upcoming events – BioMarin and Argos get ready to deliver

September 11, 2015

Upcoming events: Readouts could mean an IPO for Afferent and a licence for Bavarian

Load More